Cialis (Tadalafil) Safety for Young Adults Ages 18 to 29
At a glance
- Approved uses / erectile dysfunction, benign prostatic hyperplasia, and ED with BPH; prescription only [1][2]
- ED dosing as needed / start 10 mg, range 5 to 20 mg, no more than once a day [1]
- ED dosing daily / start 2.5 mg at about the same time each day, may increase to 5 mg [1]
- Peak blood level / median 2 hours after a dose (range 30 minutes to 6 hours) [1]
- Half-life / mean terminal half-life about 17.5 hours in healthy subjects [1]
- Contraindications / any organic nitrate, riociguat, prior serious hypersensitivity to tadalafil [1]
- Side effects at 20 mg as needed / headache 15%, dyspepsia 10%, back pain 6%, versus 5%, 1% and 3% on placebo [1]
- Blood pressure in healthy volunteers / mean maximal supine fall of 1.6/0.8 mm Hg versus placebo [1]
What doses are approved, and does age change them?
Drugs@FDA lists the Cialis 5 mg, 10 mg and 20 mg tablets as prescription products; the 2.5 mg tablet is listed as discontinued [2]. For ED taken as needed, the label's starting dose is 10 mg before sexual activity; it can be raised to 20 mg or lowered to 5 mg depending on response and tolerability, with a maximum of one dose a day [1]. Once-daily use for ED starts at 2.5 mg at about the same time every day and may go to 5 mg; for BPH, and for ED with BPH, the dose is 5 mg once daily [1]. The label says the tablets may be taken with or without food and should not be split [1].
The label sets no separate dose for a 22-year-old. Its adjustments are for kidney and liver function and for interacting drugs, not age: as-needed use is capped at 5 mg every 72 hours when creatinine clearance is below 30 mL/min or on hemodialysis, and daily use is not recommended in that group [1].
The label says tadalafil improved erectile function compared with placebo for up to 36 hours after a dose, not that it produces an erection that lasts 36 hours. Sexual stimulation is still required, and an erection lasting more than 4 hours needs emergency care [1].
What are the serious risks in the Cialis label?
Nitrates. Cialis is contraindicated in anyone using any form of organic nitrate, whether regularly or intermittently [1]. In a crossover study of 150 men given tadalafil 20 mg or placebo daily for seven days and then sublingual nitroglycerin 0.4 mg, standing systolic blood pressure fell below 85 mm Hg in more men on tadalafil at 4, 8 and 24 hours, with no difference at 48, 72 and 96 hours [3]. The label's emergency rule is narrow: in a life-threatening situation where a nitrate is medically necessary, at least 48 hours should pass after the last Cialis dose, and the nitrate is then given only under close medical supervision with hemodynamic monitoring [1]. That is a hospital rule, not a green light to combine the two.
Riociguat and hypersensitivity. Guanylate cyclase stimulators such as riociguat are contraindicated, and so is use in anyone with a known serious hypersensitivity to tadalafil, including reported Stevens-Johnson syndrome and exfoliative dermatitis [1].
Priapism. An erection lasting more than 4 hours, painful or not, needs emergency care; painful erections longer than 6 hours are priapism and can cause irreversible damage to erectile tissue [1]. The label advises caution in sickle cell anemia, multiple myeloma, leukemia, and penile deformity such as angulation, cavernosal fibrosis or Peyronie's disease [1].
Heart risk from the activity itself. Sexual activity carries some cardiac risk, so ED drugs should not be used by men for whom sexual activity is inadvisable because of cardiovascular status [1]. The label does not recommend Cialis in several groups that were not included in its trials: myocardial infarction within 90 days, unstable angina or angina during intercourse, NYHA class 2 or greater heart failure within 6 months, uncontrolled arrhythmia, blood pressure below 90/50 mm Hg or uncontrolled hypertension, and stroke within 6 months [1].
Vision and hearing. Non-arteritic anterior ischemic optic neuropathy (NAION) has been reported rarely after marketing with all PDE5 inhibitors; the label cites an annual incidence of 2.5 to 11.8 cases per 100,000 in men aged 50 and older and two observational case-crossover studies suggesting about a 2-fold risk (estimates 2.15, 95% CI 1.06 to 4.34, and 2.27, 95% CI 0.99 to 5.20), while stating that neither the reports nor the studies establish causation [1]. Sudden hearing decrease or loss, sometimes with tinnitus and dizziness, has also been reported, and the label says it cannot tell whether it is directly related to the drug [1].
For sport, tadalafil is not named on the WADA 2026 Prohibited List or the 2027 list [4][5].
What are the common side effects, and how often do they happen?
The label's numbers come from eight 12-week placebo-controlled trials of as-needed Cialis for ED (placebo n=476; tadalafil 10 mg n=394; 20 mg n=635) [1]. At 20 mg versus placebo: headache 15% versus 5%, dyspepsia 10% versus 1%, back pain 6% versus 3%, myalgia 3% versus 1%, nasal congestion 3% versus 1%, flushing 3% versus 1%, and pain in limb 3% versus 1% [1]. Discontinuation because of adverse events was 3.1% on 10 or 20 mg versus 1.4% on placebo [1].
With once-daily ED dosing (placebo n=248; 2.5 mg n=196; 5 mg n=304), headache was 5% on placebo versus 3% at 2.5 mg and 6% at 5 mg, and dyspepsia 2% versus 4% and 5%; discontinuation was 4.1% on tadalafil versus 2.8% on placebo [1].
In clinical pharmacology trials, back pain and muscle pain generally began 12 to 24 hours after dosing and typically resolved within 48 hours, and about 0.5% of men using Cialis as needed stopped because of them [1].
Does tadalafil affect fertility or testosterone?
On hormones, the Cialis label reports no adverse effect of tadalafil 10 or 20 mg on mean testosterone, luteinizing hormone, or follicle-stimulating hormone concentrations versus placebo [1]. Cialis is indicated for ED, BPH, and ED with BPH, not for low testosterone [1]. Adcirca is a different tadalafil product, approved for pulmonary arterial hypertension [6].
On semen and sperm, the evidence is mixed. A 2008 review of PDE5 inhibitors and sperm described the study results as controversial: some showed no significant effect on sperm motility, viability and morphology in men treated with these drugs, while others showed improved motility [7]. The Cialis label notes that less than 0.0005% of a dose appears in semen [1].
Which interactions matter most in your 20s?
Alcohol. Alcohol and tadalafil are both mild vasodilators, and substantial drinking (5 units or more) with Cialis can increase orthostatic signs and symptoms: higher heart rate, lower standing blood pressure, dizziness and headache [1]. Tadalafil did not change alcohol levels and alcohol did not change tadalafil levels [1].
Alpha-blockers such as doxazosin, tamsulosin and alfuzosin lower blood pressure too, and the effect is additive. In healthy volunteers, tadalafil 20 mg with doxazosin 8 mg daily produced a placebo-subtracted maximal standing systolic fall of 9.8 mm Hg [1]. For ED, the label advises that a person should already be stable on the alpha-blocker and that tadalafil should be started at the lowest dose. For BPH, the combination is not recommended [1].
CYP3A4 inhibitors. Tadalafil is metabolized mainly by CYP3A4. Ketoconazole 400 mg daily raised tadalafil 20 mg exposure (AUC) by 312% and peak concentration by 22%; ketoconazole 200 mg daily raised tadalafil 10 mg AUC by 107% [1]. Ritonavir 200 mg twice daily raised tadalafil 20 mg AUC by 124% [1]. The label's caps are 10 mg every 72 hours for as-needed use and 2.5 mg for daily use [1].
CYP3A4 inducers. Rifampin 600 mg daily cut tadalafil 10 mg AUC by 88% and peak concentration by 46%; the label says no dose adjustment is needed, but the efficacy of once-daily Cialis may fall by an unknown amount [1].
Should ED at 20 to 29 be investigated?
The Cialis label calls for an assessment of potential underlying causes of ED, as well as treatment options [1]. A 2017 review noted that in younger men organic, psychological and relational factors can all contribute, and that metabolic and cardiovascular risk factors are surprisingly relevant in this age group [8].
In one series of 439 consecutive men seeking first medical help for new ED, 114 (26%) were 40 or younger, with a mean age of 32.4 [9]. Those younger men had fewer comorbid conditions than the older group but smoked and used illicit drugs more often, and 48.8% had severe ED on the IIEF, a rate not significantly different from older men [9].
When does the label say to get emergency help?
The Cialis label tells patients to seek emergency treatment if an erection lasts more than 4 hours, to stop the drug and seek medical care for sudden loss of vision in one or both eyes, and to stop and seek prompt medical attention for a sudden decrease or loss of hearing [1]. It also says patients who experience symptoms upon initiation of sexual activity should refrain from further sexual activity and seek immediate medical attention, and that patients who experience anginal chest pain after taking Cialis should seek immediate medical attention because of the nitrate question [1]. Suspected reactions can be reported to FDA at 1-800-FDA-1088 or www.fda.gov/medwatch [1].
Frequently asked questions
Is tadalafil safe for a 20-year-old?
Can I drink alcohol while taking tadalafil?
Can tadalafil be taken with nitrates?
Does tadalafil affect testosterone or sperm?
How long does tadalafil stay in the body?
Can a 22-year-old take tadalafil every day?
References
- U.S. National Library of Medicine, DailyMed. Cialis (tadalafil) tablets, Lilly prescribing information. Cialis (tadalafil) tablets, Lilly label
- Drugs@FDA: FDA-Approved Drugs. Drugs@FDA: FDA-Approved Drugs
- Kloner RA, Hutter AM, Emmick JT, Mitchell MI, Denne J, Jackson G. Time course of the interaction between tadalafil and nitrates. J Am Coll Cardiol. 2003;42(10):1855-60. Time course of the interaction between tadalafil and nitrates
- World Anti-Doping Agency. World Anti-Doping Agency
- World Anti-Doping Agency. World Anti-Doping Agency
- Drugs@FDA: FDA-Approved Drugs. Drugs@FDA: FDA-Approved Drugs
- Dimitriadis F, Giannakis D, Pardalidis N, Zikopoulos K, Paraskevaidis E, Giotitsas N, et al. Effects of phosphodiesterase-5 inhibitors on sperm parameters and fertilizing capacity. Asian J Androl. 2008;10(1):115-33. Effects of phosphodiesterase-5 inhibitors on sperm parameters and fertilizing capacity
- Rastrelli G, Maggi M. Erectile dysfunction in fit and healthy young men: psychological or pathological?. Transl Androl Urol. 2017;6(1):79-90. Erectile dysfunction in fit and healthy young men: psychological or pathological?
- Capogrosso P, Colicchia M, Ventimiglia E, Castagna G, Clementi MC, Suardi N, et al. One patient out of four with newly diagnosed erectile dysfunction is a young man--worrisome picture from the everyday clinical practice. J Sex Med. 2013;10(7):1833-41. One patient out of four with newly diagnosed erectile dysfunction is a young man--worrisome picture from the everyday clinical practice